Early home return after prostate tumor removal
Part of Cancer clinical trials.
This trial checks whether it’s safe for patients to go home sooner after an endoscopic prostate procedure that removes the enlarged-tissue. It may help reduce hospital time while still keeping patients closely monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for an endoscopic prostate tissue removal using a laser
- You have symptoms from an enlarged prostate that have not improved with medicines, or you have urine blockage that keeps coming back, or prostatitis (prostate inflammation)
- You can have nurse support at home within the trial’s service area
- You are not bedridden, and you are not very ill (WHO condition score 2 or less)
- If you take blood thinners, they can be paused or switched to a home-manageable option like heparin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial tests whether using real-time ultrasound during endoscopic prostate surgery helps surgeons remove prostate tissue more completely and safely. Men aged 50-80 with an enlarged prostate who are scheduled for certain types of prostate surgery may be eligible.
This trial tests a precise, short-course radiation treatment (stereotactic body radiotherapy) after prostate removal surgery that adapts to your body each day to reduce side effects. It is for people whose prostate cancer has high-risk features or a rising PSA after surgery.
This Phase 3 trial studies whether taking curcumin (a supplement made from turmeric) after radical prostatectomy can help keep prostate cancer from coming back. Participants are men with low-risk, surgery-only disease and undetectable PSA, and the study checks recurrence-free survival over time.
This trial tests a shorter, stronger course of radiation (hypofractionated radiotherapy) given after prostate removal surgery. It may help people whose PSA levels rise again after surgery, aiming to reduce side effects and improve outcomes.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) for men who have already had their prostate removed and still have signs of cancer (like rising PSA). The goal is to see if this can help prevent the cancer from coming back.
Hear when a new Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.